# A Food Effect Study of SPH5030 Tablets.

> **NCT06372223** · PHASE1 · COMPLETED · sponsor: **Shanghai Pharmaceuticals Holding Co., Ltd** · enrollment: 16 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** SPH5030
- **DRUG:** SPH5030

## Key facts

- **NCT ID:** NCT06372223
- **Lead sponsor:** Shanghai Pharmaceuticals Holding Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-04
- **Primary completion:** 2024-03-25
- **Final completion:** 2024-03-25
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06372223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06372223, "A Food Effect Study of SPH5030 Tablets.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06372223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*